These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 3584925

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of portal hypertension with isosorbide dinitrate alone and in combination with vasopressin.
    Hallemans R, Naeije R, Mols P, Mélot C, Reding P.
    Crit Care Med; 1983 Jul; 11(7):536-40. PubMed ID: 6861502
    [Abstract] [Full Text] [Related]

  • 3. Effects of isosorbide-5-mononitrate on variceal pressure and systemic and splanchnic haemodynamics in patients with cirrhosis.
    Escorsell A, Feu F, Bordas JM, García-Pagán JC, Luca A, Bosch J, Rodés J.
    J Hepatol; 1996 Apr; 24(4):423-9. PubMed ID: 8738728
    [Abstract] [Full Text] [Related]

  • 4. Hemodynamic effects of combined treatment with somatostatin analogue (SMS 201-995) and low-dose isosorbide dinitrate on portal hypertension in conscious cirrhotic rats.
    Hori N, Okanoue T, Sawa Y, Itoh Y, Mori T, Takami S, Kashima K.
    J Gastroenterol; 1994 Aug; 29(4):460-8. PubMed ID: 7951857
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Systemic and regional hemodynamic effects of isosorbide dinitrate in patients with liver cirrhosis and portal hypertension.
    Mols P, Hallemans R, Melot C, Lejeune P, Naeije R.
    J Hepatol; 1989 May; 8(3):316-24. PubMed ID: 2732445
    [Abstract] [Full Text] [Related]

  • 7. Reduction of portal pressure by chronic administration of isosorbide dinitrate in patients with cirrhosis: effects on systemic and splanchnic hemodynamics and liver function.
    Ikegami M, Toyonaga A, Tanikawa K.
    Am J Gastroenterol; 1992 Sep; 87(9):1160-4. PubMed ID: 1519573
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Isosorbide dinitrate in experimental portal hypertension: a study of factors that modulate the hemodynamic response.
    Blei AT, Gottstein J.
    Hepatology; 1986 Sep; 6(1):107-11. PubMed ID: 3943776
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Propranolol compared with propranolol plus isosorbide dinitrate in portal-hypertensive patients: long-term hemodynamic and renal effects.
    Vorobioff J, Picabea E, Gamen M, Villavicencio R, Bordato J, Bessone F, Tanno H, Palazzi J, Sarano H, Pozzoli L.
    Hepatology; 1993 Sep; 18(3):477-84. PubMed ID: 8359793
    [Abstract] [Full Text] [Related]

  • 13. Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis.
    Garcia-Pagán JC, Navasa M, Bosch J, Bru C, Pizcueta P, Rodés J.
    Hepatology; 1990 Feb; 11(2):230-8. PubMed ID: 2307401
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of peroral administration of isosorbide dinitrate on portal pressure and blood flow in patients with cirrhosis of the liver.
    Cervinka J, Kordac V, Kalab M.
    J Int Med Res; 1989 Feb; 17(6):560-4. PubMed ID: 2628133
    [Abstract] [Full Text] [Related]

  • 20. Effect of octreotide on systemic, central, and splanchnic haemodynamics in cirrhosis.
    Møller S, Brinch K, Henriksen JH, Becker U.
    J Hepatol; 1997 May; 26(5):1026-33. PubMed ID: 9186833
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.